http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CS-195707-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69c91bbf0395db010b4806f50d808c4e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D243-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D243-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
filingDate 1975-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c028ee521b90b04c109b0f3f202ea0d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cb3729b65365bcb045a0eea5415c2ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b74b41802e27e4cb95002ad06584670f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d436576e28a456240b8e1bff991c37de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e6cce3e4af81a1e51af4e530e70409b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_604b6c87ca20151ccbf4a88a27f93fce
publicationDate 1980-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CS-195707-B2
titleOfInvention Method of producing novel n up 4-substituted derivatives of 1,3,4,5-tetrahydro-2h-1,4-benzodiazepine-2-one
abstract 1509445 Benzodiazepines RICHTER GEDEON VEGYESZETI GYAR RT 25 June 1975 [25 June 1974] 26920/75 Heading C2C Compounds of the general formula (R 1 =halogen, CF 3 , NO 2 , NH 2 ; R 2 =H, alkyl; R 3 =NO, NH 2 , optionally substituted alkylideneamino, aralkylideneamino or acylamino) are prepared by nitrosating the 4-unsubstituted compound, optionally followed by (a) reduction and (if required) reaction with an aldehyde or acylating agent, and/or (b) alkylation. Any amino substituent(s) in the aldehyde or acylating agent may be protected during the reaction. The above compounds possess enzymeinducing properties, and may be administered in the form of pharmaceutical preparations containing them in association with a carrier.
priorityDate 1974-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420277257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152749552
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419574411
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID192746
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6577
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3608
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53744844
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415870804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430992738
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422939975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451195432
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458437694
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514216
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148431
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4277
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559481
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420275914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88825791
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21437113
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21437106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21437107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420275953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589015
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420276321
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1117
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21437119
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54304737
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420276901

Total number of triples: 74.